The largest database of trusted experimental protocols

Ultramdck media

Manufactured by Lonza

UltraMDCK media is a chemically defined, animal component-free cell culture medium designed for the growth and maintenance of various mammalian cell lines. It provides a balanced formulation of nutrients, vitamins, and other essential components to support cell proliferation and survival.

Automatically generated - may contain errors

4 protocols using ultramdck media

1

Influenza Virus Neutralization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDCK cells (100 µL/well) were seeded at a concentration of 2 × 105 cells/mL in 96-well cell culture plates (Sigma) and incubated at 37 °C for 12 h. The mAbs were diluted to a starting concentration of 30 µg/mL in PBS and serially diluted 1:2 in UltraMDCK media (Lonza) supplemented with tosyl phenylalanyl chloromethyl ketone-treated trypsin (infection media; Sigma) at a concentration of 1 µg/mL, in 96-well cell culture plates (Sigma). The viruses were diluted to a concentration of 100 × TCID50/50 µL (A/Hunan/02285/2017 (Hunan), A/feline/New York/16-040082/2016 (New York), A/Hong Kong/2014/2017 (Hong Kong)) in infection medium. Next, 60 µL of virus dilution was incubated with 60 µL of mAb serial dilution and incubated on the shaker at room temperature for 1 h. The plates were incubated at 33 °C for 48h  (New York) or 72 h (Hunan, Hong Kong). The readout was performed by the means of classical hemagglutination assay. This readout was chosen because it is more objective than assessment of cytopathic effects but easier to perform than staining for virus antigen (e.g., for nucleoprotein). In brief, chicken RBCs (Lampire Biological Laboratories) was diluted to a concentration of 0.5% in PBS and added to 50 µL of cell supernatant in v-bottom plates (Corning). After 45–60 min the plates were scanned and the results analyzed in Microsoft Excel and GraphPad Prism 7.
+ Open protocol
+ Expand
2

SARS-CoV-2 Antibody Neutralization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A549 cells were maintained in DMEM supplemented with 10% FBS, 10 U ml−1 penicillin, and 10 mg ml−1 streptomycin) and were plated in 96-well, white-walled plates (Costar) at 2.5 × 105 cells per ml overnight at 37 °C with 5% CO2. The following day, cells were washed with PBS and infected with A/Netherlands/602/2009 at a multiplicity of infection of 5 in UltraMDCK media (Lonza) for 24 h in the absence of TPCK-treated trypsin. mAbs were serially diluted in assay buffer (RPMI 1640 supplemented with 4% ultra-low IgG FBS; Gibco), starting at 60 μg ml−1 and diluted threefold. Cell medium was aspirated and 25 μl of assay buffer and 25 μl of diluted antibody were added to each well. Jurkat cells expressing human FcgRIIIa with a NFAT-driven luciferase reporter gene (Promega) were diluted to 3 × 106 cells per ml, 25 μl of cells was added to each well and incubated at 37 °C with 5% CO2 for 6 h. Plates were removed from the incubator and placed at room temperature for 15 min. Of the BioGlo luciferase substrate (Promega), 75 μl was added to each well and luminescence was read immediately using a Syngery H1 hybrid multimode microplate reader (Biotek). EC50 values were determined using Prism 8 (GraphPad).
+ Open protocol
+ Expand
3

Isolation and Expansion of Human Renal Epithelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human renal epithelial cells (REC) were isolated from human kidneys unsuitable for transplantation due to anatomic or fibrotic defects (procured from the National Disease Research Interchange, NDRI), following an established method.10 (link) For all tissues used, provided by NDRI, written informed consent was obtained according to Institutional Review Board (IRB) #5 at the University of Pennsylvania. Cells were cultured in Ultra MDCK media (Lonza, Walkersville, MD) supplemented with 1/2× the manufacturer’s recommended dilution for insulin, transferrin, ethanolamine and selenium supplement (ITES, Lonza), 60ng/mL epidermal growth factor (EGF, #E1257 Sigma-Aldrich; St. Louis, MO), 10−9M triiodothyronine (T3, #T6397, Sigma-Aldrich, St Louis, MO) and antibiotic-antimycotic (15240-062, Invitrogen, Carlsbad, CA). Cells were passaged upon 70–80% confluence, and either seeded on carbon disks or frozen for future seeding. This process called expanded propagation (EP) was carried out using a recently developed culture system10 (link).
+ Open protocol
+ Expand
4

Escape Mutant Generation and Analysis of Influenza A Virus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Virus escape mutants were generated as previously described (68 (link)). Ten TCID50 of A/Netherlands/602/2009 virus was incubated with 1:5 IC50 of mAb for 1 hour. Virus/mAb mixtures were added to 500,000 MDCK cells for 1 hour. Cells were washed with PBS and plated with 2ml Ultra MDCK media (Lonza) supplemented with 1 μg/ml TPCK-treated trypsin and corresponding mAb concentrations. After two days, supernatants were collected, and HA assays were performed to determine viral growth. Wells with virus were incubated with 2x increase of mAb for one hour before addition to MDCK cells. Virus grown in the absence of mAb was included for all mAbs to control for passage-associated mutations. The virus was grown with increasing concentration of mAb until 64–128x IC50 of mAb was achieved, typically 10–16 passages. After an escape mutant was generated, supernatants were collected, viral RNA was collected and purified using QIAamp Viral RNA Mini Kit (Qiagen), cDNA was generated using SuperScript III (Invitrogen), HA sequences were amplified using A/Netherlands/602/2009 specific HA primers, and sequenced by Sanger sequencing. Sequences were analyzed using Librator (in-house software) and Clustal Omega (European Bioinformatics Institute). Mutations were visualized on A/California/4/2009 HA (PDB: 4jtv) using Pymol (Schrödinger).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!